Iclusig PMS in CML or Ph+ALL Patients

NCT03709017 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myeloid Leukemia
Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Interventions

DRUG: Ponatinib

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.